Your browser doesn't support javascript.
loading
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.
Johnston, Stephen; Trudeau, Maureen; Kaufman, Bella; Boussen, Hamouda; Blackwell, Kimberley; LoRusso, Patricia; Lombardi, Donald P; Ben Ahmed, Slim; Citrin, Dennis L; DeSilvio, Michelle L; Harris, Jennifer; Westlund, Ron E; Salazar, Vanessa; Zaks, Tal Z; Spector, Neil L.
Afiliación
  • Johnston S; Department of Medicine-Breast Unit, Royal Marsden Hospital, London, United Kingdom.
J Clin Oncol ; 26(7): 1066-72, 2008 Mar 01.
Article en En | MEDLINE | ID: mdl-18212337
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quinazolinas / Neoplasias de la Mama / Biomarcadores de Tumor / Receptor ErbB-2 / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2008 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quinazolinas / Neoplasias de la Mama / Biomarcadores de Tumor / Receptor ErbB-2 / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2008 Tipo del documento: Article País de afiliación: Reino Unido